h1

h2

h3

h4

h5
h6
% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Biancacci:963252,
      author       = {Biancacci, Ilaria and De Santis, Daniele and Rama, Elena
                      and Benderski, Karina and Momoh, Jeffrey and Pohlberger,
                      Robert and Moeckel, Diana and Kaps, Leonard and Rijcken,
                      Cristianne J. F. and Prakash, Jai and Thewissen, Marielle
                      and Kiessling, Fabian and Shi, Yang and Peña, Quim and
                      Sofias, Alexandros Marios and Consolino, Lorena and Lammers,
                      Twan},
      title        = {{R}epurposing tamoxifen for tumor microenvironment priming
                      and enhanced tumor‐targeted drug delivery},
      journal      = {Advanced therapeutics},
      volume       = {6},
      number       = {11},
      issn         = {2366-3987},
      address      = {Weinheim},
      publisher    = {Wiley-VCH Verlag},
      reportid     = {RWTH-2023-07692},
      pages        = {2300098},
      year         = {2023},
      cin          = {811003-3 ; 924210},
      ddc          = {610},
      cid          = {$I:(DE-82)811003-3_20140620$},
      pnm          = {OA - Open Access Publikation mit Unterstützung der
                      Universitätsbibliothek der RWTH Aachen University
                      (X021000-OA) / Meta-Targeting - Macro-Nanomedicine to Treat
                      Metastatic Cancer (864121) / GRK 2375 - GRK 2375:
                      Tumor-Targeted Drug Delivery (331065168) / DFG project
                      213555243 - SFB 1066: Nanodimensionale polymere Therapeutika
                      für die Tumortherapie (213555243) / BMBF 16GW0319K -
                      Wirkstofftransport: Paclitaxel-beladene polymere Mizellen
                      (Pizellen) für die Behandlung von Triple-negativem
                      Brustkrebs (PP-TNBC) - Von der Synthese über Wirksamkeit in
                      die Klinik (16GW0319K)},
      pid          = {G:(DE-82)X021000-OA / G:(EU-Grant)864121 /
                      G:(GEPRIS)331065168 / G:(GEPRIS)213555243 /
                      G:(BMBF)16GW0319K},
      typ          = {PUB:(DE-HGF)16},
      UT           = {WOS:001030812100001},
      doi          = {10.1002/adtp.202300098},
      url          = {https://publications.rwth-aachen.de/record/963252},
}